Condition

COVID-19 (1)

Chagas Disease (1)

Plaque Psoriasis (1)

Rheumatoid Arthritis (1)

Overall Status

Completed (2)

Not yet recruiting (1)

Unknown status (1)

Phase

n/a (2)

Sponsor

Hamad Medical Corporation (1)

Microbio Co Ltd (1)

Olive View-UCLA Education & Research Institute (1)

US Department of Veterans Affairs (1)

Collaborator

Canadian Institutes of Health Research (CIHR) (1)

Centers for Disease Control and Prevention (1)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1)

Qatar University (1)

Rheumatoid Arthritis Investigational Network (RAIN) (1)

Weill Cornell Medical College in Qatar (1)

Intervention

5% natural lactic acid-enriched cream (1)

etanercept (1)

hydroxychloroquine (1)

methotrexate (1)

no intervention (1)

placebo, etanercept (1)

placebo, triple (1)

sulfasalazine (1)

trypanosoma cruzi serology (1)

Study Documents

Intervention Type

device (1)

drug (1)

other (1)

procedure (1)

Funder Type

Industry (2)

Other (1)

U.S. Fed (1)

Study Type

Interventional (2)

Observational (2)

antiparasitics

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Plaque Psoriasis Trial (5% Natural Lactic Acid-enriched Cream)

Not yet recruiting

Plaque Psoriasis

5% Natural Lactic Acid-enriched Cream

(no location specified)

Oct 13, 2021

Immune Profiling of COVID19-patients Admitted to ICU

Unknown status

COVID-19

No intervention

Doha, Qatar

Hamad Medical Corporation

Jul 15, 2020

Chagas Disease in Immigrant Conduction Abnormalities on

Completed

Chagas Disease

Trypanosoma cruzi serology

Sylmar, California

OV-UCLA Medical Center

Mar 11, 2019

Rheumatoid Arthritis Trial in Canada, United States (Etanercept, methotrexate, Sulfasalazine)

Completed

Has Results

Rheumatoid Arthritis

Etanercept
+5 more

Loma Linda, California
+36 more

Nov 7, 2013